BridgeMD
New treatment option for Minocycline
Official title Minocycline for Chronic Autoimmune Uveitis
ClinicalTrials.gov ID: NCT05474729
What this study is testing
What is minocycline?
minocycline is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for minocycline.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Autoimmune uveitis is one kind of non-infectious, sight-threatening, relapsing and severe ocular disease. Approximately 20%-25% autoimmune uveitis patients suffer from the dilemma of blindness for the chronic and persistent inflammatory state in the eyes, which results in continuous destroy in the structure of the eyes and gradually leads to irreversible damage on visual function.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Participant diagnosed of autoimmune diseases with visual function damage (decrease of BCVA, loss of retinal structure)
- Participant aged from 18-60 years old.
- Participant that signed the informed consent document and is able to complete the following visits.
You likely can't join if
- Participant is allergy to minocycline or tetracyclines.
- Participant has no contraindications of minocycline or tetracyclines.
- Participant has an abnormal function of liver, heart, kidney and thyroid.
- Participant is using glucocorticoids, immunosuppressants or biologics.
- Female that is pregnant, breast-feeding or planning to become pregnant.
- Participant that is currently using other medications for other diseases.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.